Cancer immunotherapy: paradigms, practice and promise
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York, NY
Springer
2013
|
| Schlagworte: | |
| Online-Zugang: | FAN01 UBT01 Volltext Inhaltsverzeichnis Abstract |
| Beschreibung: | 1 Online-Ressource |
| ISBN: | 9781461447313 9781461447320 |
| DOI: | 10.1007/978-1-4614-4732-0 |
Internformat
MARC
| LEADER | 00000nmm a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV040746864 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 130213s2013 |||| o||u| ||||||eng d | ||
| 020 | |a 9781461447313 |9 978-1-4614-4731-3 | ||
| 020 | |a 9781461447320 |c Online |9 978-1-4614-4732-0 | ||
| 024 | 7 | |a 10.1007/978-1-4614-4732-0 |2 doi | |
| 035 | |a (OCoLC)823887950 | ||
| 035 | |a (DE-599)HBZTT050417497 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-703 |a DE-1102 | ||
| 082 | 0 | 4 | |a 614.5999 |2 23 |
| 245 | 1 | 0 | |a Cancer immunotherapy |b paradigms, practice and promise |c Tyler J. Curiel, ed. |
| 264 | 1 | |a New York, NY |b Springer |c 2013 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Medicine | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Toxicology | |
| 650 | 0 | 7 | |a Immuntherapie |0 (DE-588)4026640-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Immuntherapie |0 (DE-588)4026640-0 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Curiel, Tyler J. |e Sonstige |0 (DE-588)141991399 |4 oth | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4614-4732-0 |x Verlag |3 Volltext |
| 856 | 4 | 2 | |m Springer Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025726669&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m Springer Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025726669&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Abstract |
| 912 | |a ZDB-2-SBL | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-025726669 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1007/978-1-4614-4732-0 |l FAN01 |p ZDB-2-SBL |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-1-4614-4732-0 |l UBT01 |p ZDB-2-SBL |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804150069504507904 |
|---|---|
| adam_text | CANCER IMMUNOTHERAPY
/
: 2013
TABLE OF CONTENTS / INHALTSVERZEICHNIS
INTRODUCTION
HISTORICAL PERSPECTIVES AND CURRENT TRENDS IN CANCER IMMUNOTHERAPY
T CELL AND ANTIGEN-PRESENTING CELL SUBSETS IN THE TUMOR MICROENVIRONMENT
ADOPTIVE T CELL TRANSFER
DENDRITIC CELL-BASED CANCER IMMUNOTHERAPY: ACHIEVEMENTS AND NOVEL
CONCEPTS
PEPTIDE AND PROTEIN-BASED CANCER VACCINES
ANTIGEN TARGETING TO DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY
CYTOKINES IN THE TREATMENT OF CANCER
IMMUNE CO-SIGNALING TO TREAT CANCE
MANAGING REGULATORY T CELLS
MYELOID-DERIVED SUPPRESSOR CELLS IN CANCER: MECHANISMS AND THERAPEUTIC
PERSPECTIVES
ANTIBODIES AS CANCER IMMUNOTHERAPY
TARGETED TOXINS IN CANCER IMMUNOTHERAPY
MISCELLANEOUS APPROACHES AND CONSIDERATIONS: TLR AGONISTS AND OTHER
INFLAMMATORY AGENTS, ANTI-CHEMOKINE AGENTS, INFECTIOUS AGENTS, TUMOR
STROMA TARGETING, AGE AND SEX EFFECTS, AND MISCELLANEOUS SMALL MOLECULES
ISSUES IN PRE-CLINICAL MODELS, CLINICAL TRIAL DESIGN AND ANALYTICAL
CONSIDERATIONS IN DEVELOPING AND EVALUATING NOVEL CANCER IMMUNOTHERAPIES
MONITORING ANTIGEN-SPECIFIC RESPONSES IN CLINICAL TRIALS OF
IMMUNOTHERAPY
INDEX
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
CANCER IMMUNOTHERAPY
/
: 2013
ABSTRACT / INHALTSTEXT
THIS VOLUME IS A COMPREHENSIVE DISCUSSION OF THE MAJOR FACTORS AFFECTING
TUMOR IMMUNOLOGY AND A DISCUSSION OF ALL MAJOR ANTI-CANCER
IMMUNOTHERAPEUTIC AGENTS APPROVED BY THE FOOD AND DRUG ADMINISTRATION OF
THE UNITED STATES AND BY EUROPEAN AGENCIES. MANY PROMISING BUT
UNAPPROVED AGENTS IN CLINICAL TRIALS ARE ALSO DISCUSSED, AS ARE KEY
PRE-CLINICAL DEVELOPMENTS. THE MAJOR CHALLENGES AND INTELLECTUAL ISSUES
FACING INVESTIGATORS DEVELOPING NOVEL IMMUNOTHERAPEUTICS ARE DISCUSSED
IN DETAIL AS ARE CONCEPTUAL DEVELOPMENTS INFLUENCING CURRENT AND FUTURE
TREATMENT STRATEGIES. EACH CHAPTER BEGINS BY DEFINING ALL RELEVANT KEY
TERMS AND CONCEPTS AND PROVIDES PERTINENT BACKGROUND INFORMATION SO THAT
THE TEXT WILL BE ACCESSIBLE TO NEWCOMERS TO THE FIELD AS WELL AS TO THE
EXPERT. THIS TEXT BOOK SHOULD PROVIDE AN EXCELLENT REFERENCE RESOURCE
FOR INVESTIGATORS IN TUMOR IMMUNOLOGY, LIFE SCIENCES STUDENTS, DRUG
DEVELOPERS DESIGNING NOVEL ANTI-CANCER IMMUNOTHERAPEUTICS, AND TO OTHER
INDIVIDUALS WITH SOME SCIENTIFIC TRAINING WISHING TO GAIN A BETTER
UNDERSTANDING OF THE FIELD OF TUMOR IMMUNOTHERAPY. ALTHOUGH THE FIELD IS
EVOLVING RAPIDLY, WE HAVE TAKEN PAINS TO ENSURE THAT INFORMATION WAS AS
UP TO DATE AS POSSIBLE AS THE TEXT WENT TO PRESS
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
|
| any_adam_object | 1 |
| author_GND | (DE-588)141991399 |
| building | Verbundindex |
| bvnumber | BV040746864 |
| collection | ZDB-2-SBL |
| ctrlnum | (OCoLC)823887950 (DE-599)HBZTT050417497 |
| dewey-full | 614.5999 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 614 - Forensic medicine; incidence of disease |
| dewey-raw | 614.5999 |
| dewey-search | 614.5999 |
| dewey-sort | 3614.5999 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-4614-4732-0 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02298nmm a2200505 c 4500</leader><controlfield tag="001">BV040746864</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">130213s2013 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461447313</subfield><subfield code="9">978-1-4614-4731-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461447320</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-4614-4732-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4614-4732-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)823887950</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)HBZTT050417497</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-1102</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">614.5999</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cancer immunotherapy</subfield><subfield code="b">paradigms, practice and promise</subfield><subfield code="c">Tyler J. Curiel, ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Springer</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Curiel, Tyler J.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)141991399</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4614-4732-0</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Springer Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025726669&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Springer Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025726669&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Abstract</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025726669</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4614-4732-0</subfield><subfield code="l">FAN01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4614-4732-0</subfield><subfield code="l">UBT01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV040746864 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T00:33:04Z |
| institution | BVB |
| isbn | 9781461447313 9781461447320 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-025726669 |
| oclc_num | 823887950 |
| open_access_boolean | |
| owner | DE-703 DE-1102 |
| owner_facet | DE-703 DE-1102 |
| physical | 1 Online-Ressource |
| psigel | ZDB-2-SBL |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | Springer |
| record_format | marc |
| spelling | Cancer immunotherapy paradigms, practice and promise Tyler J. Curiel, ed. New York, NY Springer 2013 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Medizin Medicine Oncology Toxicology Immuntherapie (DE-588)4026640-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Krebs Medizin (DE-588)4073781-0 s Immuntherapie (DE-588)4026640-0 s 2\p DE-604 Curiel, Tyler J. Sonstige (DE-588)141991399 oth https://doi.org/10.1007/978-1-4614-4732-0 Verlag Volltext Springer Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025726669&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Springer Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025726669&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Abstract 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Cancer immunotherapy paradigms, practice and promise Medizin Medicine Oncology Toxicology Immuntherapie (DE-588)4026640-0 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4026640-0 (DE-588)4073781-0 (DE-588)4143413-4 |
| title | Cancer immunotherapy paradigms, practice and promise |
| title_auth | Cancer immunotherapy paradigms, practice and promise |
| title_exact_search | Cancer immunotherapy paradigms, practice and promise |
| title_full | Cancer immunotherapy paradigms, practice and promise Tyler J. Curiel, ed. |
| title_fullStr | Cancer immunotherapy paradigms, practice and promise Tyler J. Curiel, ed. |
| title_full_unstemmed | Cancer immunotherapy paradigms, practice and promise Tyler J. Curiel, ed. |
| title_short | Cancer immunotherapy |
| title_sort | cancer immunotherapy paradigms practice and promise |
| title_sub | paradigms, practice and promise |
| topic | Medizin Medicine Oncology Toxicology Immuntherapie (DE-588)4026640-0 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Medizin Medicine Oncology Toxicology Immuntherapie Krebs Medizin Aufsatzsammlung |
| url | https://doi.org/10.1007/978-1-4614-4732-0 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025726669&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025726669&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT curieltylerj cancerimmunotherapyparadigmspracticeandpromise |